Randomized, Investigator-Blinded Study to Compare the Efficacy and Tolerance of a 650-microsecond, 1064-nm YAG Laser to a 308-nm Excimer Laser for the Treatment of Mild to Moderate Psoriasis Vulgaris

February 2020 | Volume 19 | Issue 2 | Original Article | 176 | Copyright © February 2020


Published online January 9, 2020

Mark S. Nestor MD PhD,a Daniel Fischer DO MS,a David Arnold DOa

aCenter for Clinical and Cosmetic Research, Aventura, FL bDepartment of Dermatology and Cutaneous Surgery, Department of Surgery, Division of Plastic Surgery, University of Miami Miller School of Medicine, Miami, FL

treatment of localised psoriasis. J Dermatolog Treat. 2017;28:8-13.
9. Fritz K, Salavastru C. The 308 nm excimer laser for the treatment of psoriasis and inflammatory skin diseases. Hautarzt. 2018;69:35-43.
10. Khatri KA, Lee RA, Goldberg LJ, Khatri B, Garcia V. Efficacy and safety of a 0.65 millisecond pulsed portable ND: YAG laser for hair removal. J Cosmet Laser Ther. 2009; 11: 19-24.
11. Cook-Bolden F. A novel 0.65 millisecond pulsed 1064 nm laser to treat skin of color without skin cooling or anesthetics. J Drugs Dermatol. 2011; 10(12 Suppl): s10-1.
12. Burgess C, Chilukuri S, Campbell-Chambers DA, et al. Practical applications for medical and aesthetic treatment of skin of color with a new 650-microsecond laser. J Drugs Dermatol. 2019;18:s138 - s143.
13. Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd: YAG 1064-nm laser. J Cosmet Laser Ther. 2011;13:2-5.
14. Rose AE, Goldberg DJ. Successful treatment of facial telangiectasias using a micropulse 1,064-nm neodymium-doped yttrium aluminum garnet laser. Dermatol Surg. 2013;39:1062-1066.
15. Gold MH, Goldberg DJ, Nestor MS. Current treatments of acne: medications, lights, lasers, and a novel 650-μs 1064-nm Nd: YAG laser. J Cosmet Dermatol. 2017;16:303-318.
16. Roberts WE, Henry M, Burgess C, et al. Laser treatment of skin of color for medical and aesthetic uses with a new 650-microsecond nd:yag 1064nm laser. J Drugs Dermatol. 2019;18:s135-s137.

AUTHOR CORRESPONDENCE

Mark Nestor MD PhD nestormd@admcorp.com
Close Menu